The presence of CD19CAR-positive T cells in tumor tissues was recorded through immune histology by staining with fluorochrome-labelled antibodies specific for CD19, CD3, and CD19scFv (FMC63) antigen epitopes. The gene discussed is CD19; the disease is neoplasm.